EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimal treatment conditions for low-intensity pulsed ultrasound therapy for Alzheimer’s disease: applications from mice to humans

Tomohiko Shindo, Kumiko Eguchi, Yuto Monma, Hiroshi Kanai, Satoshi Yasuda, Hiroaki Shimokawa

Journal of Medical Ultrasonics · 2024-07 · 51 (3) · 419-427

DOI: 10.1007/s10396-024-01461-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Ultrasonics, online erschienen am 02.05.2024. Verfasst von Tomohiko Shindo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machiachiachi, Aoba-Kuuu, Sendai, Miyagi, 980-8574, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Ultrasonic Therapy, Nitric Oxide Synthase Type III, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We previously developed a novel therapy with low-intensity pulsed ultrasound (LIPUS) that ameliorates cognitive decline through upregulation of endothelial nitric oxide synthase (eNOS) in mouse models of Alzheimer’s disease (AD). In a randomized, double-blind, placebo-controlled pilot trial, we demonstrated that whole-brain LIPUS therapy is safe and tends to suppress the cognitive decline in early AD patients. We herein report the findings of our basic experiments that we performed for the pilot trial in order to apply whole-brain LIPUS therapy to humans, as well.

Methods

First, we examined the relationship between bone density/thickness and ultrasound transmittance using human temporal bone. Next, based on the results of ultrasound transmittance, we further examined mRNA expression of VEGF, FGF2, and eNOS in response to variable ultrasound frequencies, duty cycles, and sound pressures.

Results

There was a significant correlation between bone thickness and transmittance (1.0 MHz, P < 0.001), while there was no significant correlation between bone density and transmittance (1.0 MHz, P = 0.421). At a frequency of 0.5 MHz, the optimum duty cycle was considered to be up to 20%. When the tissue amplitude was in the range of 0.05–0.5 MPa, VEGF, FGF2, and eNOS were significantly upregulated by LIPUS. Thus, the conditions necessary for LIPUS therapy for the human brain were identified as sound pressure just below the probe 1.3 MPa (tissue amplitude 0.15 MPa), duty cycle 5%, and frequency 0.5 MHz.

Conclusion

We successfully identified the optimal treatment conditions for LIPUS therapy for patients with AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseUltrasonic TherapyNitric Oxide Synthase Type IIIVascular Endothelial Growth Factor AHumansAnimalsMiceUltrasonic WavesFibroblast Growth Factor 2MaleFemaleBone DensityPilot ProjectsAgedBrainDouble-Blind Method

Stichwörter der Autor:innen

Alzheimer’s diseaseDementiaLow-intensity pulsed ultrasoundNitric oxide synthaseVascular endothelial growth factor

Substanzen

Nitric Oxide Synthase Type IIIVascular Endothelial Growth Factor AFibroblast Growth Factor 2

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machiachiachi, Aoba-Kuuu, Sendai, Miyagi, 980-8574, Japan.
  • Division of Biomedical Measurements and Diagnostics, Graduate School of Biomedical Engineering, Tohoku University, Sendai, Miyagi, Japan.
  • Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machiachiachi, Aoba-Kuuu, Sendai, Miyagi, 980-8574, Japan. shimo@cardio.med.tohoku.ac.jp.
  • Graduate School, International University of Health and Welfare, 4-3 Kozunomori, Narita, Chiba, 286-8686, Japan. shimo@cardio.med.tohoku.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Shindo, T., Eguchi, K., Monma, Y., Kanai, H., Yasuda, S., & Shimokawa, H. (2024). Optimal treatment conditions for low-intensity pulsed ultrasound therapy for Alzheimer’s disease: applications from mice to humans. Journal of Medical Ultrasonics, 51(3), 419-427. https://doi.org/10.1007/s10396-024-01461-9

Vancouver

Shindo T, Eguchi K, Monma Y, Kanai H, Yasuda S, Shimokawa H. Optimal treatment conditions for low-intensity pulsed ultrasound therapy for Alzheimer’s disease: applications from mice to humans. Journal of Medical Ultrasonics. 2024;51(3):419-427. doi:10.1007/s10396-024-01461-9

BibTeX
@article{Shindo2024,
  author = {Shindo, Tomohiko and Eguchi, Kumiko and Monma, Yuto and Kanai, Hiroshi and Yasuda, Satoshi and Shimokawa, Hiroaki},
  title = {Optimal treatment conditions for low-intensity pulsed ultrasound therapy for Alzheimer’s disease: applications from mice to humans},
  journal = {Journal of Medical Ultrasonics},
  year = {2024},
  volume = {51},
  number = {3},
  pages = {419--427},
  doi = {10.1007/s10396-024-01461-9}
}
Kostenlos starten →